- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A journalist alleged a Daily Mail Online story was covert promotion of Xolair linked to Novartis contacts and a pack shot. PMCPA…
Ipsen UK was ruled in breach of Clause 9.1 after supporting an ISU urology meeting at a 5-star Belfast venue where the…
An ex-employee alleged a meeting invitation remained on an events website after an undertaking was signed. The Panel ruled Gedeon Richter failed…
Ex-employee complaint about Esmya meeting invites for Barcelona. Panel found unacceptable meeting arrangements and lack of certification (2013), plus promotion of an…
Otsuka admitted an RBM emailed sales teams to “move” HCPs from 2–4 to 8–9 calls in a fortnight and to follow up…
Shire distributed a Lancet reprint to promote Replagal that contained an incorrect bar chart comparing renal function decline vs Fabrazyme. Appeal Board…
An NHS commissioning lead alleged Novo Nordisk staff told nurses he’d been dismissed for misconduct. The Panel found the complainant provided no…
Anonymous allegation that Allergan made large payments to doctors to endorse Botox and other products. Complainant provided no details and became non-contactable.…
Napp funded UK HCPs to attend a 2‑day Remsima promotional meeting in Norway. PMCPA found no clear reason to hold it abroad,…
Anonymous ex-employee alleged an unapproved slide deck was used at a Chiesi sales conference. Panel found the session was a general compliance…
Actelion challenged two GSK Volibris leavepieces: an ERA drug–drug interaction table and a Stockley’s interaction chart described as funded by an “educational…
A pharmacist challenged a Striverdi Respimat leavepiece showing an older woman cycling, alleging the artwork overstated likely COPD benefit. The PMCPA Panel…
Anonymous complaint alleged a Genzyme employee suggested monthly (off-licence) liver monitoring for Aubagio. Accounts conflicted and evidence was insufficient; the Panel ruled…
A GP alleged a Pfizer representative used subterfuge and urgency to get through to him via reception. The Panel found the call…
Public complaint about alleged late/non-disclosure of trial results for Conbriza and Xiapex. Panel initially found breaches for Xiapex, but Appeal Board ruled…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.